YONKERS, N.Y.--(BUSINESS WIRE)--Advanced Viral Research Corporation (OTCBB: ADVR), a research based biopharmaceutical company dedicated to anti-cancer drug discovery and development, announced today it has appointed the life sciences marketing communications firm The Signature Agency to assist in its overall branding and investor communications. Advanced Viral Research Corporation is developing a new class of cytoprotective drug which may be useful in the treatment of cachexia (body wasting), appetite loss, and lethargy in patients with cancer and HIV-AIDS. The compound also is being evaluated in a Phase II topical wound healing study after demonstrating accelerated wound healing properties in a well established animal model at the University of Miami.
